286 related articles for article (PubMed ID: 21961888)
1. Systematic review of cost and cost-effectiveness of different TB-screening strategies.
Nienhaus A; Schablon A; Costa JT; Diel R
BMC Health Serv Res; 2011 Sep; 11():247. PubMed ID: 21961888
[TBL] [Abstract][Full Text] [Related]
2. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.
Pooran A; Booth H; Miller RF; Scott G; Badri M; Huggett JF; Rook G; Zumla A; Dheda K
BMC Pulm Med; 2010 Feb; 10():7. PubMed ID: 20170555
[TBL] [Abstract][Full Text] [Related]
3. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
4. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
[TBL] [Abstract][Full Text] [Related]
5. Comparing the cost-effectiveness of two screening strategies for latent tuberculosis infection in Portugal.
Sousa S; Rocha D; Silva JC; Ribeiro AI; Gonçalves G; Almeida Á; Correia AM; Duarte R; Carvalho C
Pulmonology; 2021; 27(6):493-499. PubMed ID: 34053903
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
Kowada A; Takasaki J; Kobayashi N
J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
[TBL] [Abstract][Full Text] [Related]
7. Priorities for screening and treatment of latent tuberculosis infection in the United States.
Linas BP; Wong AY; Freedberg KA; Horsburgh CR
Am J Respir Crit Care Med; 2011 Sep; 184(5):590-601. PubMed ID: 21562129
[TBL] [Abstract][Full Text] [Related]
8. Cost analysis of tuberculin skin test and the QuantiFERON-TB Gold In-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA.
Nijhawan AE; Iroh PA; Brown LS; Winetsky D; Porsa E
BMC Infect Dis; 2016 Oct; 16(1):564. PubMed ID: 27733123
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.
Steffen RE; Caetano R; Pinto M; Chaves D; Ferrari R; Bastos M; de Abreu ST; Menzies D; Trajman A
PLoS One; 2013; 8(4):e59546. PubMed ID: 23593145
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.
Vassilopoulos D; Tsikrika S; Hatzara C; Podia V; Kandili A; Stamoulis N; Hadziyannis E
Clin Vaccine Immunol; 2011 Dec; 18(12):2102-8. PubMed ID: 21994356
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes.
Kowada A
Epidemiol Infect; 2016 Nov; 144(15):3215-3225. PubMed ID: 27412626
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers.
del Campo MT; Fouad H; Solís-Bravo MM; Sánchez-Uriz MA; Mahíllo-Fernández I; Esteban J
Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1226-34. PubMed ID: 23143360
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke.
Kowada A
Int J Tuberc Lung Dis; 2015 Jul; 19(7):857-63. PubMed ID: 26056114
[TBL] [Abstract][Full Text] [Related]
14. Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis.
Pareek M; Bond M; Shorey J; Seneviratne S; Guy M; White P; Lalvani A; Kon OM
Thorax; 2013 Mar; 68(3):230-9. PubMed ID: 22693179
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study of concordance and costs between tuberculin skin test and QuantiFERON(®)-TB Gold In-Tube in the diagnosis of latent tuberculosis infection among contacts of patients with pulmonary tuberculosis].
Martinez Lacasa X; Canals Font R; Jaen Manzanera A; Cuchi Burgos E; Lite Lite J
Med Clin (Barc); 2015 Nov; 145(10):427-32. PubMed ID: 25794770
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of contact screening strategies for tuberculosis among high-school adolescents in South Korea.
Sohn H; Kim HY; Lee SH
Int J Tuberc Lung Dis; 2018 May; 22(5):496-503. PubMed ID: 29663953
[TBL] [Abstract][Full Text] [Related]
17. Pre-placement screening for tuberculosis in healthcare workers.
Giri P; Basu S; Sargeant T; Rimmer A; Pirzada O; Adisesh A
Occup Med (Lond); 2014 Oct; 64(7):524-9. PubMed ID: 25135937
[TBL] [Abstract][Full Text] [Related]
18. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
[TBL] [Abstract][Full Text] [Related]
19. Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment.
Yoopetch P; Chitpim N; Jittikoon J; Udomsinprasert W; Thavorncharoensap M; Youngkong S; Praditsitthikorn N; Mahasirimongkol S; Chaikledkaew U
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294107
[TBL] [Abstract][Full Text] [Related]
20. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
Haukaas FS; Arnesen TM; Winje BA; Aas E
Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
